Skip to main content
. 2013 Oct 30;5(11):4316–4332. doi: 10.3390/nu5114316

Table 1.

Body weight gains after 84 days of continuous oral treatment of fRG in HFD-fed mice.

Groups Body weights (g): Body weight gains during (g):
At start of administration At a termination Adapt period (7 days) Administration period (84 days)
ND 27.54 ± 0.88 33.01 ± 2.28 2.04 ± 0.63 5.48 ± 1.58
HFD 31.04 ± 2.12 a 50.20 ± 10.44 a 5.63 ± 1.36 a 19.16 ± 11.02 a
+Simvastatin 30.40 ± 1.90 a 39.70 ± 3.28 a,c 4.51 ± 0.93 a 9.33 ± 2.82 b,c
+Silymarin 30.24 ± 0.94 a 44.61 ± 7.88 a 5.38 ± 1.14 a 14.38 ± 7.53 a
+Metformin 30.41 ± 1.71 a 39.31 ± 4.81 ac 5.09 ± 1.25 a 8.90 ± 4.36 c
+RG 250 mg/kg 30.29 ± 1.22 a 44.54 ± 9.23 a 4.54 ± 0.76 a 14.25 ± 8.33 b
+fRG 500 mg/kg 30.19 ± 1.19 a 39.28 ± 9.48 4.84 ± 0.86 a 9.09 ± 9.27
+fRG 250 mg/kg 30.30 ± 1.11 a 44.31 ± 5.81 a 4.58 ± 1.16 a 14.01 ± 5.66 a
+fRG 125 mg/kg 30.58 ± 1.29 a 42.56 ± 7.83 a 4.94 ± 1.00 a 11.99 ± 8.86

Values were expressed mean ± S.D. of eight mice (Significant as compared with ND-fed mice, a p < 0.01; b p < 0.05; significant as compared with HFD-fed mice; c p < 0.05; RG, Red Ginseng; fRG, Red-koji fermented RG; HFD, high fat diet).